Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) has provided an update.
Dishman Carbogen Amcis Ltd. has released an investor presentation in compliance with SEBI regulations, which is now available on their website. This move is part of the company’s commitment to transparency and regular communication with stakeholders, potentially impacting investor relations positively.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. operates in the pharmaceutical industry, focusing on providing contract research and manufacturing services. The company is known for its expertise in the development and production of active pharmaceutical ingredients (APIs) and intermediates, catering to a global market.
Average Trading Volume: 15,243
Technical Sentiment Signal: Strong Buy
Current Market Cap: 42.86B INR
Find detailed analytics on DCAL stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges
- Elon Musk’s 2018 Stock Shares Go Live, Tesla Stock (NASDAQ:TSLA) Slips